Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

New SARS-CoV-2 variant emerges in the U.S.

Even as the rollout of vaccines all over the world brings a glimmer of hope that the current coronavirus disease 2019 (COVID-19) pandemic may end in the near future, new variants continue to emerge, some with the potential to escape vaccine-induced or therapeutic antibodies. Now, a new preprint research paper published on the bioRxiv server describes a new American variant that may have become the dominant strain in the USA.

18 Jan 2021

A high-temperature tolerant SARS-CoV-2 derived immunogen as a potential vaccine candidate

There have been significant efforts worldwide to combat COVID-19, the disease caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). One prominent strategy has been to develop vaccines against the virus. Numerous vaccine candidates are under development, and a handful have now been approved for use by several countries.

17 Jan 2021

Research suggests St. John's Wort and Echinacea could protect against COVID-19

Researchers in Saudi Arabia have conducted a study demonstrating the antiviral effects of two medicinal herbs against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the agent that causes coronavirus disease 2019 (COVID-19).

17 Jan 2021

When covid deaths aren’t counted, families pay the price

On Sundays, Bishop Bruce Davis preached love. Through his Pentecostal ministry, he organized youth parades and gave computers, bicycles and food to families in need.

15 Jan 2021

Image-based deep learning haplotype-guided study maps the global adaptation of SARS-CoV-2

A new study used deep learning with image recognition technology to trace the emergence of variants with increased viral fitness. Higher fitness leads to rapid expansion of these lineages in the areas where they are introduced. This type of study could facilitate the development of more effective antibodies and vaccines to help contain the pandemic.

15 Jan 2021

What are the SARS-CoV-2 exposure risks for workers on mink farms?

A new study reports on the risk of COVID-19 among workers on these farms, and in the communities living around such farms.

15 Jan 2021

Can cloth masks protect healthcare professionals from SARS-CoV-2?

Given the global scarcity of surgical masks, a recent review study examines this issue - dealing with the potential use of cloth masks in healthcare scenarios.

15 Jan 2021

5 reasons to wear a mask even after you’re vaccinated

As an emergency physician, Dr. Eugenia South was in the first group of people to receive a covid vaccine. She received her second dose last week — even before President-elect Joe Biden.

15 Jan 2021

Jellagen launches JellaGel™, the first Collagen Type 0 Hydrogel taking on the market leading Extracellular Matrix

Jellagen® Limited, a biotechnology company manufacturing high-value Collagen Type 0 derived from jellyfish, announce the launch of their JellaGel™ Hydrogel.

From Jellagen 15 Jan 2021

New DNA test quickly identifies secondary infections in COVID-19 patients

Researchers have developed a DNA test to quickly identify secondary infections in COVID-19 patients, who have double the risk of developing pneumonia while on ventilation than non-COVID-19 patients.

15 Jan 2021

Targeting RNA splicing can activate antiviral immune pathways in triple negative breast cancers

Researchers at Baylor College of Medicine have discovered how therapeutics targeting RNA splicing can activate antiviral immune pathways in triple negative breast cancers (TNBC) to trigger tumor cell death and signal the body's immune response.

15 Jan 2021

Omega-3 diet helps Arctic ground squirrels to hibernate a little warmer than normal

By feeding arctic ground squirrels special diets, researchers have found that omega-3 fatty acids, common in flax seed and fish oil, help keep the animals warmer in deep hibernation.

15 Jan 2021

Lab study reveals effective treatment for COVID-19

A new potential therapy for COVID-19 developed by researchers at Rush University Medical Center has shown success in preventing the disease's symptoms in mice.

14 Jan 2021

Excess COVID-19 deaths in overwhelmed Israeli hospitals

Researchers in Israel have conducted a study showing that increased hospital load due to rising coronavirus disease 2019 (COVID-19) cases resulted in higher COVID-19-related mortality, despite hospitals not exceeding their defined threshold for meeting patients' treatment needs.

14 Jan 2021

A snake venom enzyme shows anti-SARS-CoV-2 activity in vitro

A new study reports the virucidal and fusion-inhibiting attributes of snake venom against the COVID-19 agent SARS-CoV-2.

14 Jan 2021

Could intranasal SARS-CoV-2 vaccines be a practical alternative to intramuscular shots?

The unchecked advance of COVID-19 has made it a top public health priority to produce a vaccine capable of inducing a safe and powerful protective response against its causative pathogen: SARS-CoV-2. An encouraging new study shows the immunogenicity, safety, and protective efficacy, of a Newcastle disease virus (NDV)-based intranasal vector vaccine in animal studies.

14 Jan 2021

Influenza drug enisamium a potential COVID-19 treatment

Researchers in Europe and the United States have demonstrated the potential of the influenza drug enisamium as a treatment for infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the agent that causes coronavirus disease 2019 (COVID-19).

13 Jan 2021

COVID-19 survivors can show persistent symptoms six months after recovery, study finds

A team of researchers conduct a large study exploring the persistence of COVID-19 symptoms in recovered patients.

13 Jan 2021

Moderna to develop three new mRNA-based vaccines against HIV, influenza, and the Nipah virus

Morderna has announced plans to develop a range of new mRNA-based vaccines against other viruses, including the influenza virus, human immunodeficiency virus (HIV), and the Nipah virus.

13 Jan 2021

New N501 SARS-CoV-2 mutation may have been circulating in Italy since August 2020

A recent study shows that mutated SARS-CoV-2 strains with a substitution at position 501 might have circulated unnoticed even before the end of September 2020, when the rapid emergence of B.1.1.7 lineage (carrying the N501Y mutation) was initially reported.

13 Jan 2021

Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

New SARS-CoV-2 variant emerges in the U.S.

A high-temperature tolerant SARS-CoV-2 derived immunogen as a potential vaccine candidate

Research suggests St. John's Wort and Echinacea could protect against COVID-19

When covid deaths aren’t counted, families pay the price

Image-based deep learning haplotype-guided study maps the global adaptation of SARS-CoV-2

What are the SARS-CoV-2 exposure risks for workers on mink farms?

Can cloth masks protect healthcare professionals from SARS-CoV-2?

5 reasons to wear a mask even after you’re vaccinated

Jellagen launches JellaGel™, the first Collagen Type 0 Hydrogel taking on the market leading Extracellular Matrix

New DNA test quickly identifies secondary infections in COVID-19 patients

Targeting RNA splicing can activate antiviral immune pathways in triple negative breast cancers

Omega-3 diet helps Arctic ground squirrels to hibernate a little warmer than normal

Lab study reveals effective treatment for COVID-19

Excess COVID-19 deaths in overwhelmed Israeli hospitals

A snake venom enzyme shows anti-SARS-CoV-2 activity in vitro

Could intranasal SARS-CoV-2 vaccines be a practical alternative to intramuscular shots?

Influenza drug enisamium a potential COVID-19 treatment

COVID-19 survivors can show persistent symptoms six months after recovery, study finds

Moderna to develop three new mRNA-based vaccines against HIV, influenza, and the Nipah virus

New N501 SARS-CoV-2 mutation may have been circulating in Italy since August 2020

PromoCell's New GMP Certification - EXCiPACT

Treating post-infectious smell loss in COVID-19 patients

A paper-based sensor for detecting COVID-19

Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

Newsletters you may be interested in